{"url_path":"/sec/dgx/10-k/2026/item-10","section_key":"item-10","section_title":"Item 10 Directors, Executive Officers and Corporate Governance","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-02-26","source_url":"https://www.sec.gov/Archives/edgar/data/1022079/0001022079-26-000015-index.html","accession_number":"0001022079-26-000015","cik":"0001022079","ticker":"DGX","issuer_name":"QUEST DIAGNOSTICS INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1022079/0001022079-26-000015-index.html","primary_entity_key":"0001022079","primary_entity_name":"QUEST DIAGNOSTICS INC"},"word_count":225,"has_tables":true,"body_markdown":"Item 10. Directors, Executive Officers and Corporate Governance\n\n    Our Code of Ethics applies to all employees, executive officers and directors, including our Chief Executive Officer, Chief Financial Officer and Corporate Controller. You can find our Code of Ethics on our corporate governance website, www.QuestDiagnostics.com/investor. We will post any amendments to the Code of Ethics, and any waivers that are required to be disclosed by the rules of either the SEC or the New York Stock Exchange, on our website.\n\n    Information regarding the Company's executive officers is contained in Part I, Item 1 of this Report under “Information about our Executive Officers.” Information regarding the directors and executive officers of the Company appearing in our Proxy Statement to be filed by April 30, 2026 (“Proxy Statement”) under the captions “Proposal No. 1 - Election of Directors,” “Director Independence,” “Board Committees” and \"Delinquent Section 16(a) Reports\" is incorporated by reference herein.\n\n    We have an insider trading policy related to the purchase, sale and other transactions in our securities entered into by our directors, officers, employees and related other persons and by us. The insider trading policy is designed to comply and promote compliance with the securities laws and related rules and regulations, the New York Stock Exchange listing standards and our own Code of Ethics. Our insider trading policy is filed as Exhibit 19 to this Report."}